{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:57:36Z","timestamp":1771012656699,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1038\/nm1296-1379","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:22:41Z","timestamp":1092878561000},"page":"1379-1382","source":"Crossref","is-referenced-by-count":33,"title":["Epstein\u2013Barr virus\u2013driven gene therapy for EBV\u2013related lymphomas"],"prefix":"10.1038","volume":"2","author":[{"given":"Michael","family":"Franken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Estabrooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Cavacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Sherburne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Scadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm12961379_CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/JVI.66.1.496-504.1992","volume":"66","author":"CM Rooney","year":"1992","unstructured":"Rooney, C.M. et al. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. J. Virol. 66, 496\u2013504 (1992).","journal-title":"J. Virol."},{"key":"BFnm12961379_CR2","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JVI.65.8.4101-4106.1991","volume":"65","author":"F Wang","year":"1991","unstructured":"Wang, F., Kikutani, H., Tsang, S. Kishimoto, T. & Kieff, E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65, 4101\u20134106 (1991).","journal-title":"J. Virol."},{"key":"BFnm12961379_CR3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/JVI.64.4.1855-1858.1990","volume":"64","author":"D Ghosh","year":"1990","unstructured":"Ghosh, D. & Kieff, E. cis-Acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site. J. Virol. 64, 1855\u20131858 (1990).","journal-title":"J. Virol."},{"key":"BFnm12961379_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.65.1.415-423.1991","volume":"65","author":"U Zimber-Strobl","year":"1991","unstructured":"Zimber-Strobl, U. et al. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65, 415\u2013423 (1991).","journal-title":"J. Virol."},{"key":"BFnm12961379_CR5","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.91.16.7568","volume":"91","author":"SR Grossman","year":"1994","unstructured":"Grossman, S.R., Johannsen, E. Tong, X., Yalamanchili, R. & Kieff, E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J\u03ba recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91, 7568\u20137572 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8016657","volume":"265","author":"T Henkel","year":"1994","unstructured":"Henkel, T., Ling, P.D., Hayward, S.D. & Peterson, M.G. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265, 92\u201395 (1994).","journal-title":"Science"},{"key":"BFnm12961379_CR7","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1073\/pnas.84.22.8060","volume":"84","author":"A Calendar","year":"1987","unstructured":"Calendar, A. et al. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 84, 8060\u20138064 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1089\/hum.1994.5.12-1507","volume":"5","author":"AB Deisseroth","year":"1994","unstructured":"Deisseroth, A.B., Kavanagh, J. & Champlin, R. Use of safety-modified retro-viruses to introduce chemotherapy during the therapy of ovarian cancer: A pilot trial. Hum. Gene Ther. 5, 1507\u20131522 (1994).","journal-title":"Hum. Gene Ther."},{"key":"BFnm12961379_CR9","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539\u20133543 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR10","first-page":"107","volume":"1","author":"DS Shewach","year":"1994","unstructured":"Shewach, D.S. et al. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gem Ther. 1, 107\u2013112 (1994).","journal-title":"Cancer Gem Ther."},{"key":"BFnm12961379_CR11","doi-asserted-by":"publisher","first-page":"9747","DOI":"10.1073\/pnas.92.21.9747","volume":"92","author":"X Han","year":"1995","unstructured":"Han, X., Kasahara, N. & Kan, Y.W. Ligand-directed retroviral targeting of human breast cancer cells. Proc. Natl. Acad. Sci. USA 92, 9747\u20139751 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR12","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.1073\/pnas.88.18.8039","volume":"88","author":"BE Huber","year":"1991","unstructured":"Huber, B.E., Richards, C.A. & Krenitsky, T.A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039\u20138043 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR13","first-page":"962","volume":"53","author":"RG Vile","year":"1993","unstructured":"Vile, R.G. & Hart, I.R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res. 53, 962\u2013967 (1993).","journal-title":"Cancer Res."},{"key":"BFnm12961379_CR14","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1093\/annonc\/5.suppl_1.S113","volume":"5","author":"D Rea","year":"1994","unstructured":"Rea, D. et al. Epstein-Barr virus latent and replicative gene expression in posttransplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors. Ann. Oncol. 5 (Suppl. 1), S113\u2013S116 (1994).","journal-title":"Ann. Oncol."},{"key":"BFnm12961379_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/00001622-199309000-00012","volume":"5","author":"DM Knowles","year":"1993","unstructured":"Knowles, D.M. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma. Curr. Opin. Oncol. 5, 845\u2013851 (1993).","journal-title":"Curr. Opin. Oncol."},{"key":"BFnm12961379_CR16","first-page":"1072","volume":"143","author":"SJ Hamilton-Dutoit","year":"1993","unstructured":"Hamilton-Dutoit, S.J. et al Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am. J. Pathol. 143, 1072\u20131085 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnm12961379_CR17","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1212\/WNL.43.11.2358","volume":"43","author":"R Bashir","year":"1993","unstructured":"Bashir, R., Luka, J., Cheloha, K., Chamberlain, M. & Hochberg, F. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 43, 2358\u20132362 (1993).","journal-title":"Neurology"},{"key":"BFnm12961379_CR18","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1200\/JCO.1993.11.9.1674","volume":"11","author":"A Carbone","year":"1993","unstructured":"Carbone, A., Tirelli, U., Gloghini, A., Volpe, R. & Boiocchi, M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J. Clin. Oncol. 11, 1674\u20131681 (1993).","journal-title":"J. Clin. Oncol."},{"key":"BFnm12961379_CR19","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1073\/pnas.93.9.4192","volume":"93","author":"TL daCosta","year":"1996","unstructured":"daCosta, T.L., Jen, J., He, T.C., Chen, T.A. & Kinzler, K.W. Converting cancer genes into killer genes. Proc. Natl. Acad. Sci. USA 93, 4192\u20134196 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12961379_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00198237","volume":"73","author":"R Hasegawa","year":"1995","unstructured":"Hasegawa, R., Emi, N. & Shimokata, K. Retroviral transfer of HSV1-TK gene into human lung cancer cell line. J. Mol. Med. 73, 107\u2013112 (1995).","journal-title":"J. Mol. Med."},{"key":"BFnm12961379_CR21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1317968","volume":"256","author":"KW Culver","year":"1992","unstructured":"Culver, K.W. et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550\u20131552 (1992).","journal-title":"Science"},{"key":"BFnm12961379_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng0895-430","volume":"10","author":"RK Hurford","year":"1995","unstructured":"Hurford, R.K., Dranoff, G., Mulligan, R.C. & Tepper, R.I. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature Genet. 10, 430\u2013435 (1995).","journal-title":"Nature Genet."},{"key":"BFnm12961379_CR23","first-page":"87","volume":"2","author":"EM Oshiro","year":"1995","unstructured":"Oshiro, E.M. et al Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells. Cancer Gene Ther. 2, 87\u201395 (1995).","journal-title":"Cancer Gene Ther."},{"key":"BFnm12961379_CR24","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1128\/MCB.11.6.3374","volume":"11","author":"SD Lupton","year":"1991","unstructured":"Lupton, S.D., Brunton, L.L., Kalberg, V.A. & Overell, R.W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell. Biol. 11, 3374\u20133378 (1991).","journal-title":"Mol Cell. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1296-1379","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1296-1379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1296-1379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:23:35Z","timestamp":1684448615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1296-1379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["BFnm12961379"],"URL":"https:\/\/doi.org\/10.1038\/nm1296-1379","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}